Your browser doesn't support javascript.
loading
Tumour biology, metastatic sites and taxanes sensitivity as determinants of eribulin mesylate efficacy in breast cancer: results from the ERIBEX retrospective, international, multicenter study.
Dell'Ova, Mélodie; De Maio, Eléonora; Guiu, Séverine; Roca, Lise; Dalenc, Florence; Durigova, Anna; Pinguet, Frédéric; Bekhtari, Khedidja; Jacot, William; Pouderoux, Stéphane.
Afiliação
  • Dell'Ova M; Département de Pharmacie Clinique, Institut régional du Cancer de Montpellier (ICM), 208, rue des Apothicaires, 34298, Montpellier Cedex 5, France. Melodie.DellOva@chu-fortdefrance.fr.
  • De Maio E; Medical Oncology Department, Institut Claudius Regaud, IUCT- Oncopole, Toulouse, France. DeMaio.Eleonora@iuct-oncopole.fr.
  • Guiu S; Medical Oncology Department, Centre Georges-François Leclerc, Dijon, France. sguiu@cgfl.fr.
  • Roca L; Breast Center (CePO), University Hospital CHUV, Rue du Bugnon 46, 1011, Lausanne, Switzerland. sguiu@cgfl.fr.
  • Dalenc F; Département de Biostatistiques, Institut régional du Cancer de Montpellier (ICM), 208, rue des Apothicaires, 34298, Montpellier Cedex 5, France. Lise.Roca@icm.unicancer.fr.
  • Durigova A; Medical Oncology Department, Institut Claudius Regaud, IUCT- Oncopole, Toulouse, France. dalenc.florence@iuct-oncopole.fr.
  • Pinguet F; Département d'Oncologie Médicale, Institut régional du Cancer de Montpellier (ICM), 208, rue des Apothicaires, 34298, Montpellier Cedex 5, France. Anna.DurigovaAbdouh@hcuge.ch.
  • Bekhtari K; Medical Oncology Department, University Hospital of Geneva, Gabrielle-Perret-Gentil 4, 1211, Geneva, Switzerland. Anna.DurigovaAbdouh@hcuge.ch.
  • Jacot W; Département de Pharmacie Clinique, Institut régional du Cancer de Montpellier (ICM), 208, rue des Apothicaires, 34298, Montpellier Cedex 5, France. Frederic.Pinguet@icm.unicancer.fr.
  • Pouderoux S; Département de Pharmacie Clinique, Institut régional du Cancer de Montpellier (ICM), 208, rue des Apothicaires, 34298, Montpellier Cedex 5, France. khedidja.Bekhtari@icm.unicancer.fr.
BMC Cancer ; 15: 659, 2015 Oct 08.
Article em En | MEDLINE | ID: mdl-26449988

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Resistencia a Medicamentos Antineoplásicos / Taxoides / Furanos / Cetonas / Antineoplásicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Resistencia a Medicamentos Antineoplásicos / Taxoides / Furanos / Cetonas / Antineoplásicos Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article